Relapsed Ewing Sarcoma

specific

Ewing sarcoma which has recurred after treatment and/or remission. While initial complete responses are not uncommon, there is a fair chance of relapse as late as one to two decades after initial therapy.

Centers

Active Trials

$1M

Cancer Funding

Top Centers for Relapsed Ewing Sarcoma(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
2	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
3	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive Active Research Program	Active Research Program	1	—	60.5
4	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	60.5
5	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	60.5
6	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	—	$471K	60.2
7	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	—	$440K	57.0
8	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program	Active Research Program	—	$460K	53.9
9	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	—	—	50.7
10	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive		—	—	38.0
11	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	—	38.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →